tiprankstipranks
Trending News
More News >
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
US Market
Advertisement

Zealand Pharma (ZLDPF) Ratios

Compare
166 Followers

Zealand Pharma Ratios

ZLDPF's free cash flow for Q2 2025 was kr1.00. For the 2025 fiscal year, ZLDPF's free cash flow was decreased by kr and operating cash flow was kr0.89. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
15.09 6.25 6.73 5.15 2.16
Quick Ratio
15.08 6.23 6.73 4.80 2.08
Cash Ratio
6.43 1.58 5.47 3.38 1.49
Solvency Ratio
4.27 -1.75 -1.29 -0.87 -1.08
Operating Cash Flow Ratio
6.69 -1.50 -4.82 -3.63 -1.19
Short-Term Operating Cash Flow Coverage
431.11 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 15.44Bkr 1.39Bkr 592.46Mkr 581.77Mkr 497.51M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.06 0.29 0.38 0.06
Debt-to-Equity Ratio
0.03 0.07 0.54 0.85 0.10
Debt-to-Capital Ratio
0.02 0.07 0.35 0.46 0.09
Long-Term Debt-to-Capital Ratio
0.02 0.00 0.28 0.41 0.00
Financial Leverage Ratio
1.10 1.24 1.89 2.23 1.64
Debt Service Coverage Ratio
123.39 -22.31 -15.56 -176.21 -204.01
Interest Coverage Ratio
193.45 -19.75 -14.46 -256.71 -286.27
Debt to Market Cap
0.01 0.00 0.03 0.10 0.00
Interest Debt Per Share
6.14 2.62 10.82 18.46 3.20
Net Debt to EBITDA
-0.94 0.51 0.71 0.47 1.27
Profitability Margins
Gross Profit Margin
100.06%94.41%70.47%59.39%74.37%
EBIT Margin
79.58%-198.34%-880.49%-257.99%-189.81%
EBITDA Margin
79.85%-190.08%-850.96%-249.41%-165.16%
Operating Profit Margin
78.85%-166.94%-785.30%-358.96%-234.57%
Pretax Profit Margin
79.20%-206.79%-934.78%-351.01%-237.65%
Net Profit Margin
73.34%-205.30%-928.60%-348.01%-239.65%
Continuous Operations Profit Margin
73.34%-205.30%-928.60%-258.04%-189.27%
Net Income Per EBT
92.60%99.28%99.34%99.14%100.84%
EBT Per EBIT
100.45%123.88%119.04%97.79%101.31%
Return on Assets (ROA)
38.89%-35.54%-62.71%-49.24%-43.99%
Return on Equity (ROE)
64.52%-44.18%-118.35%-109.74%-71.93%
Return on Capital Employed (ROCE)
44.74%-33.75%-60.74%-60.59%-61.53%
Return on Invested Capital (ROIC)
41.34%-33.18%-59.69%-59.56%-61.41%
Return on Tangible Assets
38.92%-35.76%-62.71%-50.56%-44.83%
Earnings Yield
22.27%-3.33%-10.38%-16.37%-10.00%
Efficiency Ratios
Receivables Turnover
49.94 2.80 0.90 1.91 7.60
Payables Turnover
-0.02 0.21 0.17 0.45 1.29
Inventory Turnover
-0.52 2.42 23.88 1.00 1.98
Fixed Asset Turnover
67.90 2.29 0.63 1.32 1.76
Asset Turnover
0.53 0.17 0.07 0.14 0.18
Working Capital Turnover Ratio
0.74 0.26 0.08 0.28 0.37
Cash Conversion Cycle
20.43K -1.46K -1.73K -263.07 -51.46
Days of Sales Outstanding
7.31 130.29 405.84 191.44 48.02
Days of Inventory Outstanding
-696.32 151.05 15.28 363.84 184.18
Days of Payables Outstanding
-21.12K 1.74K 2.15K 818.35 283.67
Operating Cycle
-689.01 281.34 421.13 555.28 232.20
Cash Flow Ratios
Operating Cash Flow Per Share
106.64 -7.52 -20.39 -28.27 -17.95
Free Cash Flow Per Share
106.37 -7.94 -20.65 -28.79 -18.60
CapEx Per Share
0.27 0.42 0.25 0.52 0.65
Free Cash Flow to Operating Cash Flow
1.00 1.06 1.01 1.02 1.04
Dividend Paid and CapEx Coverage Ratio
396.48 -17.92 -80.46 -54.76 -27.50
Capital Expenditure Coverage Ratio
396.48 -17.92 -80.46 -54.76 -27.50
Operating Cash Flow Coverage Ratio
19.00 -3.57 -2.12 -1.54 -5.75
Operating Cash Flow to Sales Ratio
0.83 -1.24 -9.06 -4.14 -1.95
Free Cash Flow Yield
25.09%-2.13%-10.25%-19.84%-8.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
4.49 -30.01 -9.64 -6.11 -10.00
Price-to-Sales (P/S) Ratio
3.29 61.61 89.48 21.26 23.96
Price-to-Book (P/B) Ratio
1.92 13.26 11.40 6.70 7.19
Price-to-Free Cash Flow (P/FCF) Ratio
3.99 -46.99 -9.75 -5.04 -11.86
Price-to-Operating Cash Flow Ratio
3.98 -49.61 -9.88 -5.13 -12.29
Price-to-Earnings Growth (PEG) Ratio
<0.01 0.74 0.80 -0.80 -0.33
Price-to-Fair Value
1.92 13.26 11.40 6.70 7.19
Enterprise Value Multiple
3.18 -31.91 -9.81 -8.06 -13.24
Enterprise Value
23.14B 20.79B 8.68B 5.88B 7.72B
EV to EBITDA
3.18 -31.91 -9.81 -8.06 -13.24
EV to Sales
2.54 60.65 83.46 20.09 21.86
EV to Free Cash Flow
3.08 -46.26 -9.10 -4.76 -10.82
EV to Operating Cash Flow
3.07 -48.84 -9.21 -4.85 -11.21
Tangible Book Value Per Share
220.49 27.93 17.66 20.39 29.75
Shareholders’ Equity Per Share
220.68 28.15 17.66 21.64 30.68
Tax and Other Ratios
Effective Tax Rate
0.07 <0.01 <0.01 <0.01 >-0.01
Revenue Per Share
128.80 6.06 2.25 6.82 9.21
Net Income Per Share
94.46 -12.44 -20.90 -23.75 -22.07
Tax Burden
0.93 0.99 0.99 0.99 1.01
Interest Burden
1.00 1.04 1.06 1.36 1.25
Research & Development to Revenue
0.14 2.00 5.91 2.01 1.71
SG&A to Revenue
0.02 0.22 2.64 0.89 0.57
Stock-Based Compensation to Revenue
0.01 0.18 0.50 0.18 0.09
Income Quality
1.13 0.60 0.78 1.19 0.81
Currency in DKK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis